These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Damage to the power plant. TreatmentUpdate; 2002 Mar; 14(3):1-2. PubMed ID: 12033185 [No Abstract] [Full Text] [Related]
3. Anti-HIV agents. Leading to lipodystrophy. TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312 [No Abstract] [Full Text] [Related]
4. The latest word on lipodystrophy and mitochondrial toxicity (and old words that still resound). Mascolini M IAPAC Mon; 2002 Jan; 8(1):14-32. PubMed ID: 11858198 [No Abstract] [Full Text] [Related]
6. On the trail of fugitive fat: the chase turns to NRTIs. Mascolini M J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):24-43. PubMed ID: 11366871 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Brinkman K; Smeitink JA; Romijn JA; Reiss P Lancet; 1999 Sep; 354(9184):1112-5. PubMed ID: 10509516 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of treatment-induced lipid abnormalities and lipodystrophy. Smith D J HIV Ther; 2001 May; 6(2):25-7. PubMed ID: 11501199 [No Abstract] [Full Text] [Related]
11. Substitution for protease inhibitors in HIV therapy. Mikhail E N Engl J Med; 2003 Dec; 349(25):2460-1; author reply 2460-1. PubMed ID: 14689602 [No Abstract] [Full Text] [Related]
12. Cohort studies: what do they tell us? ChĂȘne G J HIV Ther; 2001 May; 6(2):28-31. PubMed ID: 11501200 [No Abstract] [Full Text] [Related]
13. Pathogenesis of HIV-associated lipodystrophy. Wanke C AIDS Clin Care; 2000 Dec; 12(12):100. PubMed ID: 12211161 [No Abstract] [Full Text] [Related]
14. Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis. Nolan D; John M; Mallal S Antivir Ther; 2001 Sep; 6(3):145-60. PubMed ID: 11808750 [TBL] [Abstract][Full Text] [Related]
15. Report from the 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Confrancesco J Hopkins HIV Rep; 2003 Jan; 15(1):4-5. PubMed ID: 12542003 [No Abstract] [Full Text] [Related]